Intas recent acquisition

Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland

Intas Pharmaceuticals Ltd., through its wholly owned subsidiary Accord Healthcare Ltd., announced today that it has entered into definitive agreements to acquire Actavis UK Ltd. & Actavis Ireland Ltd. from Teva Pharmaceutical Industries Ltd. The transaction is part of the European Commission’s anti-trust divestiture requirements arising from Teva’s acquisition of Actavis Generics.

This transaction represents a unique opportunity for Intas to build scale in the UK & Ireland - adding to the company’s market leading hospital franchise - and creates a strong platform for further European expansion. Additionally, this acquisition will make Accord a leading generics player in the UK market.

The transaction is only subject to regulatory approval, which is expected to be provided in the next three months, with completion following shortly thereafter.